Dr. Richard Tobin
pharmaceutic
LISA
Cambodia
Biography
Dr. Tobin has been a key figure in researching the Targeted Peptide Technology (TPT) over the past five years under Dr. Newell-Rogers, beginning at the University of Colorado and then at Texas. His thesis was titled, “Functional regulation of MHC class II and B-cell survival by cell surface expression of MHC II in association with CLIP.” He brings to the team a wealth of understanding and know-how as it relates to TPT. Dr. Tobin received his PhD in Medical Sciences from TexasA&M University.
Research Interest
science
